Literature DB >> 30949967

An In Vitro Study of Aromatic Stacking of Drug Molecules.

Shelley N Jackson1, Damon C Barbacci2, Antonello Bonci3, Amina S Woods4,5.   

Abstract

In this paper, drug-drug chemical interactions between two different aromatic compounds were studied by mass spectrometry. Specifically, we examined non-covalent complexes (NCX) between paclitaxel, a chemotherapeutic compound, and medications widely used in palliative care for depression, psychosis, and anxiety. It is unknown whether psychotropic medications directly interact with paclitaxel. Here, we use a simple and rapid electrospray ionization mass spectrometry in vitro assay, which has been predictive in the case of neuropeptides, to measure the relative strength of non-covalent interactions. This chemical interaction is most likely due to the overlap of aromatic rings of π-orbitals between paclitaxel and five commonly used medications: diazepam, clonozepam, sertraline, fluoxetine, and haloperidol. Molecular modeling illustrates that differences in the stability of the NCXs are likely due to the distance between the aromatic rings present in both the paclitaxel and antidepressant medications. Graphical Abstract.

Entities:  

Keywords:  Drug–drug interactions; Non-covalent interactions; π-Stacking

Mesh:

Substances:

Year:  2019        PMID: 30949967      PMCID: PMC7520095          DOI: 10.1007/s13361-019-02166-x

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.109


  26 in total

1.  Preventable medication errors: identifying and eliminating serious drug interactions.

Authors:  J F Peterson; D W Bates
Journal:  J Am Pharm Assoc (Wash)       Date:  2001 Mar-Apr

Review 2.  Noncovalent binding between guanidinium and anionic groups: focus on biological- and synthetic-based arginine/guanidinium interactions with phosph[on]ate and sulf[on]ate residues.

Authors:  Kevin A Schug; Wolfgang Lindner
Journal:  Chem Rev       Date:  2005-01       Impact factor: 60.622

3.  Electrospray ionization mass spectrometry probing of binding affinity of berbamine, a flexible cyclic alkaloid from traditional Chinese medicine, with G-quadruplex DNA.

Authors:  Wei Tan; Jiang Zhou; Gu Yuan
Journal:  Rapid Commun Mass Spectrom       Date:  2014-01-15       Impact factor: 2.419

4.  Dissociation energies of deoxyribose nucleotide dimer anions measured using blackbody infrared radiative dissociation.

Authors:  E F Strittmatter; P D Schnier; J S Klassen; E R Williams
Journal:  J Am Soc Mass Spectrom       Date:  1999-11       Impact factor: 3.109

5.  ESI-MS detection of very weak pi-stacking interactions in the mixed-ligand sandwich complexes formed by substituted benzo-crown ethers and metal cations.

Authors:  Rafał Frański; Błazej Gierczyk
Journal:  J Am Soc Mass Spectrom       Date:  2010-01-07       Impact factor: 3.109

Review 6.  Cancer and depression.

Authors:  D Spiegel
Journal:  Br J Psychiatry Suppl       Date:  1996-06

7.  Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol.

Authors:  N Klauber; S Parangi; E Flynn; E Hamel; R J D'Amato
Journal:  Cancer Res       Date:  1997-01-01       Impact factor: 12.701

8.  Phase I clinical and pharmacokinetic study of BMS-247550, a novel derivative of epothilone B, in solid tumors.

Authors:  Sridhar Mani; Hayley McDaid; Anne Hamilton; Howard Hochster; Marvin B Cohen; Dineo Khabelle; Tom Griffin; David E Lebwohl; Leonard Liebes; Franco Muggia; Susan Band Horwitz
Journal:  Clin Cancer Res       Date:  2004-02-15       Impact factor: 12.531

9.  Characterization of noncovalent complexes of antimalarial agents of the artemisinin-type and FE(III)-heme by electrospray mass spectrometry and collisional activation tandem mass spectrometry.

Authors:  Vlada A Pashynska; Hilde Van den Heuvel; Magda Claeys; Marina V Kosevich
Journal:  J Am Soc Mass Spectrom       Date:  2004-08       Impact factor: 3.109

Review 10.  Depression and cancer: mechanisms and disease progression.

Authors:  David Spiegel; Janine Giese-Davis
Journal:  Biol Psychiatry       Date:  2003-08-01       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.